
    
      This is a prospective, longitudinal, open-label, multicentre, observational, non-comparative
      national study using an exhaustive registry of implantations over a given period in France.
      The study is requested by French Health Authorities in 2010 for reimbursement renewal, to
      maintain reimbursement for pulmonary valvular replacement by bioprothesis in approved
      indication in France. The study was closed in 2013.
    
  